A recent study reveals that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle plans.
Published data in a prominent health publication shows that while obese people can lose a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these medications need to be aware of the risk of rapid rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.
That rate of recovery suggests a return to starting weight within about a year and a half.
Analyzing Therapies
The research, which examined 37 of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with older methods.
Researchers point out that people who shed pounds through dieting typically experience a more gradual creep back—approximately 0.1 kg a month—once they finish.
Understanding the Quick Regain
Experts propose the mode of action of the drugs explains the heightened rebound.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this medication results in hunger is uncontrolled, making binge eating far more likely."
A Chronic Disease?
The NHS recommend the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians say that, due to the high risk of weight regain, the therapy is often long-term.
This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the chronic nature of obesity," comparing it to managing conditions like high blood pressure.
Patient Experiences
Users who have come off the jabs explain a sudden resurgence of hunger.
"It felt as if a trigger that goes on and you become starving," recalled an individual.
This challenge is exacerbated if individuals have not established lasting lifestyle or habit modifications during therapy.
Significant Adoption
Survey data indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is higher among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, experts stress that while the jabs are effective tools for weight loss, they are not a permanent solution and lasting health benefits relies on integrated behavioural changes.
